Determination of losartan associated with chlorthalidone or hydrochlorothiazide in capsules by capillary zone electrophoresis

Detalhes bibliográficos
Autor(a) principal: Balesteros,Manoela R.
Data de Publicação: 2007
Outros Autores: Faria,Adriana F., Oliveira,Marcone A. L. de
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Journal of the Brazilian Chemical Society (Online)
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0103-50532007000300009
Resumo: An alternative methodology by capillary zone electrophoresis (CZE) is proposed for the determination of losartan potassium (LOS) associated with chlorthalidone (CTD) or hydrochlorothiazide (HCT) in capsules, using 50 mmol L-1 of sodium carbonate buffer with detection at 226 nm. The electrolyte system was optimized, taking into account peak profiles, resolution, run times, baseline stability and repeatability (adsorption absence). The method was successfully applied to the analysis of pharmaceutical formulations purchased in manipulation drugstores. The analytes were baseline separated in less than 5 min. The results did not present significant difference in the 95% confidence interval in relation to the label claim values. The method can be applied to analyze these compounds and could also be employed in other similar formulated products containing these drugs.
id SBQ-2_8f610a4a4f312f7e20fb8df4b51d7168
oai_identifier_str oai:scielo:S0103-50532007000300009
network_acronym_str SBQ-2
network_name_str Journal of the Brazilian Chemical Society (Online)
repository_id_str
spelling Determination of losartan associated with chlorthalidone or hydrochlorothiazide in capsules by capillary zone electrophoresislosartanantihypertensivediureticspharmaceutical analysiscapillary electrophoresisAn alternative methodology by capillary zone electrophoresis (CZE) is proposed for the determination of losartan potassium (LOS) associated with chlorthalidone (CTD) or hydrochlorothiazide (HCT) in capsules, using 50 mmol L-1 of sodium carbonate buffer with detection at 226 nm. The electrolyte system was optimized, taking into account peak profiles, resolution, run times, baseline stability and repeatability (adsorption absence). The method was successfully applied to the analysis of pharmaceutical formulations purchased in manipulation drugstores. The analytes were baseline separated in less than 5 min. The results did not present significant difference in the 95% confidence interval in relation to the label claim values. The method can be applied to analyze these compounds and could also be employed in other similar formulated products containing these drugs.Sociedade Brasileira de Química2007-01-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0103-50532007000300009Journal of the Brazilian Chemical Society v.18 n.3 2007reponame:Journal of the Brazilian Chemical Society (Online)instname:Sociedade Brasileira de Química (SBQ)instacron:SBQ10.1590/S0103-50532007000300009info:eu-repo/semantics/openAccessBalesteros,Manoela R.Faria,Adriana F.Oliveira,Marcone A. L. deeng2007-06-28T00:00:00Zoai:scielo:S0103-50532007000300009Revistahttp://jbcs.sbq.org.brONGhttps://old.scielo.br/oai/scielo-oai.php||office@jbcs.sbq.org.br1678-47900103-5053opendoar:2007-06-28T00:00Journal of the Brazilian Chemical Society (Online) - Sociedade Brasileira de Química (SBQ)false
dc.title.none.fl_str_mv Determination of losartan associated with chlorthalidone or hydrochlorothiazide in capsules by capillary zone electrophoresis
title Determination of losartan associated with chlorthalidone or hydrochlorothiazide in capsules by capillary zone electrophoresis
spellingShingle Determination of losartan associated with chlorthalidone or hydrochlorothiazide in capsules by capillary zone electrophoresis
Balesteros,Manoela R.
losartan
antihypertensive
diuretics
pharmaceutical analysis
capillary electrophoresis
title_short Determination of losartan associated with chlorthalidone or hydrochlorothiazide in capsules by capillary zone electrophoresis
title_full Determination of losartan associated with chlorthalidone or hydrochlorothiazide in capsules by capillary zone electrophoresis
title_fullStr Determination of losartan associated with chlorthalidone or hydrochlorothiazide in capsules by capillary zone electrophoresis
title_full_unstemmed Determination of losartan associated with chlorthalidone or hydrochlorothiazide in capsules by capillary zone electrophoresis
title_sort Determination of losartan associated with chlorthalidone or hydrochlorothiazide in capsules by capillary zone electrophoresis
author Balesteros,Manoela R.
author_facet Balesteros,Manoela R.
Faria,Adriana F.
Oliveira,Marcone A. L. de
author_role author
author2 Faria,Adriana F.
Oliveira,Marcone A. L. de
author2_role author
author
dc.contributor.author.fl_str_mv Balesteros,Manoela R.
Faria,Adriana F.
Oliveira,Marcone A. L. de
dc.subject.por.fl_str_mv losartan
antihypertensive
diuretics
pharmaceutical analysis
capillary electrophoresis
topic losartan
antihypertensive
diuretics
pharmaceutical analysis
capillary electrophoresis
description An alternative methodology by capillary zone electrophoresis (CZE) is proposed for the determination of losartan potassium (LOS) associated with chlorthalidone (CTD) or hydrochlorothiazide (HCT) in capsules, using 50 mmol L-1 of sodium carbonate buffer with detection at 226 nm. The electrolyte system was optimized, taking into account peak profiles, resolution, run times, baseline stability and repeatability (adsorption absence). The method was successfully applied to the analysis of pharmaceutical formulations purchased in manipulation drugstores. The analytes were baseline separated in less than 5 min. The results did not present significant difference in the 95% confidence interval in relation to the label claim values. The method can be applied to analyze these compounds and could also be employed in other similar formulated products containing these drugs.
publishDate 2007
dc.date.none.fl_str_mv 2007-01-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0103-50532007000300009
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0103-50532007000300009
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/S0103-50532007000300009
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Sociedade Brasileira de Química
publisher.none.fl_str_mv Sociedade Brasileira de Química
dc.source.none.fl_str_mv Journal of the Brazilian Chemical Society v.18 n.3 2007
reponame:Journal of the Brazilian Chemical Society (Online)
instname:Sociedade Brasileira de Química (SBQ)
instacron:SBQ
instname_str Sociedade Brasileira de Química (SBQ)
instacron_str SBQ
institution SBQ
reponame_str Journal of the Brazilian Chemical Society (Online)
collection Journal of the Brazilian Chemical Society (Online)
repository.name.fl_str_mv Journal of the Brazilian Chemical Society (Online) - Sociedade Brasileira de Química (SBQ)
repository.mail.fl_str_mv ||office@jbcs.sbq.org.br
_version_ 1750318167849172992